​

Thera (THTX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

THTX Stock Rating

Thera stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

THTX Price Target Upside V Benchmarks

TypeNameUpside
StockThera-
SectorHealthcare Stocks 24.81%
IndustrySpecialty & Generic Drug Manufacturers Stocks29.65%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.53$2.53$2.53
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2512---3
May, 2512---3
Apr, 25111--3
Mar, 25111--3
Feb, 25111--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 17, 2022Cantor FitzgeraldOverweightinitialise

Financial Forecast

EPS Forecast

Nov 20 Nov 21 Nov 22 Nov 23 Nov 24 Nov 25 Nov 26 Nov 27 Nov 28
Nov 20Nov 21Nov 22Nov 23Nov 24Nov 25Nov 26Nov 27Nov 28
Reported$-1.18$-1.37$-1.98$-0.91-----
Avg Forecast$-0.86$-1.03$-0.27$-0.84$0.03$0.08$0.19$0.29$0.43
High Forecast$-0.83$-0.99$-0.22$-0.83$0.04$0.09$0.20$0.30$0.45
Low Forecast$-0.88$-1.06$-0.32$-0.86$0.03$0.08$0.18$0.27$0.39
Surprise %37.21%33.01%633.33%8.33%-----

Revenue Forecast

$30M $47M $64M $81M $98M $115M Nov 20 Nov 21 Nov 22 Nov 23 Nov 24 Nov 25 Nov 26 Nov 27 Nov 28
Nov 20Nov 21Nov 22Nov 23Nov 24Nov 25Nov 26Nov 27Nov 28
Reported$66.05M$69.82M$80.06M$81.76M-----
Avg Forecast$65.13M$70.48M$39.03M$82.47M$83.92M$86.19M$92.92M$99.32M$109.56M
High Forecast$66.57M$72.04M$46.84M$85.74M$87.25M$89.61M$96.60M$103.26M$113.90M
Low Forecast$63.28M$68.48M$31.22M$77.62M$78.98M$81.13M$87.45M$93.48M$103.11M
Surprise %1.42%-0.94%105.11%-0.85%-----

Net Income Forecast

$-50M $-37M $-24M $-11M $2M $15M Nov 20 Nov 21 Nov 22 Nov 23 Nov 24 Nov 25 Nov 26 Nov 27 Nov 28
Nov 20Nov 21Nov 22Nov 23Nov 24Nov 25Nov 26Nov 27Nov 28
Reported$-22.67M$-31.73M$-47.24M$-23.96M-----
Avg Forecast$-22.65M$-27.03M$-23.70M$-23.30M$877.74K$2.19M$5.09M$7.64M$11.24M
High Forecast$-21.81M$-26.04M$-18.96M$-18.64M$923.00K$2.31M$5.35M$8.03M$11.81M
Low Forecast$-23.30M$-27.81M$-28.44M$-27.96M$810.63K$2.03M$4.70M$7.05M$10.38M
Surprise %0.09%17.35%99.30%2.82%-----

THTX Forecast FAQ

Is Thera stock a buy?

Thera stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Thera is a favorable investment for most analysts.

What is Thera's price target?

Thera's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $2.53.

How does Thera stock forecast compare to its benchmarks?

Thera's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the specialty & generic drug manufacturers stocks industry (29.65%).

What is the breakdown of analyst ratings for Thera over the past three months?

  • June 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Thera’s EPS forecast?

Thera's average annual EPS forecast for its fiscal year ending in November 2024 is $0.03, marking a -103.30% decrease from the reported $-0.91 in 2023. Estimates for the following years are $0.08 in 2025, $0.19 in 2026, $0.29 in 2027, and $0.43 in 2028.

What is Thera’s revenue forecast?

Thera's average annual revenue forecast for its fiscal year ending in November 2024 is $83.92M, reflecting a 2.64% increase from the reported $81.76M in 2023. The forecast for 2025 is $86.19M, followed by $92.92M for 2026, $99.32M for 2027, and $109.56M for 2028.

What is Thera’s net income forecast?

Thera's net income forecast for the fiscal year ending in November 2024 stands at $877.74K, representing a -103.66% decrease from the reported $-23.957M in 2023. Projections indicate $2.19M in 2025, $5.09M in 2026, $7.64M in 2027, and $11.24M in 2028.